Stephen J Rogerson

Stephen J Rogerson

orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2004 in International Journal for Parasitology
Verified
Journal Article
Closed access
KBKatja Becker
Katja Becker
LTLeann Tilley
Leann Tilley
JVJonathan L. Vennerstrom
Jonathan L. Vennerstrom
DRDavid Roberts
David Roberts
SRStephen J Rogerson
Stephen J Rogerson
HGHagai Ginsburg
Hagai Ginsburg

1 February 2007 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
SRStephen J Rogerson
Stephen J Rogerson
LHLars Hviid
Lars Hviid
PDPatrick E Duffy
Patrick E Duffy
RLRose Fg Leke
Rose Fg Leke
DTDiane W Taylor
Diane W Taylor

1 February 2002 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JKJames G. Kublin
James G. Kublin
FDFraction K. Dzinjalamala
Fraction K. Dzinjalamala
DKDeborah D. Kamwendo
Deborah D. Kamwendo
EMElissa M. Malkin
Elissa M. Malkin
JCJoseph F. Cortese
Joseph F. Cortese
CPChristopher V. Plowe
Christopher V. Plowe
Molecular assays for monitoring sulfadoxine-pyrimethamine-resistant Plasmodium falciparum have not been implemented because of the genetic and statis

16 July 2014 in Nature
Verified
Journal Article
Closed access
BEBrendan Elsworth
Brendan Elsworth
KMKathryn Matthews
Kathryn Matthews
CNCatherine Q. Nie
Catherine Q. Nie
MKMing Kalanon
Ming Kalanon
SCSarah C. Charnaud
Sarah C. Charnaud
TKTania F. de Koning-Ward
Tania F. de Koning-Ward

1 April 2018 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
SRStephen J Rogerson
Stephen J Rogerson
MDMeghna Desai
Meghna Desai
AMAlfredo Mayor
Alfredo Mayor
ESElisa Sicuri
Elisa Sicuri
STSteve M Taylor
Steve M Taylor
AEAnna M van Eijk
Anna M van Eijk

1 July 1995 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SRStephen J Rogerson
Stephen J Rogerson
SCS C Chaiyaroj
S C Chaiyaroj
KNK Ng
K Ng
JRJ C Reeder
J C Reeder
GBG V Brown
G V Brown
Adherence of Plasmodium falciparum-infected erythrocytes to cerebral postcapillary venular endothelium is believed to be a critical step in the development of cerebral malaria. Some of the possible receptors mediating adherence have been identified, but the process of adherence in vivo is poorly understood. We investigated the role of carbohydrate ligands in adherence, and we identified chondroitin sulfate (CS) as a specific receptor for P. falciparum-infected erythrocytes. Parasitized cells bound to Chinese hamster ovary (CHO) cells and C32 melanoma cells in a chondroitin sulfate-dependent manner, whereas glycosylation mutants lacking chondroitin sulfate A (CSA) supported little or no binding. Chondroitinase treatment of wild-type CHO cells reduced binding by up to 90%. Soluble CSA inhibited binding to CHO cells by 99.2 +/- 0.2% at 10 mg/ml and by 72.5 +/- 3.8% at 1 mg/ml, whereas a range of other glycosaminoglycans such as heparan sulfate had no effect. Parasite lines selected for increased binding to CHO cells and most patient isolates bound specifically to immobilized CSA. We conclude that P. falciparum can express or expose proteins at the surface of the infected erythrocyte that mediate specific binding to CSA. This mechanism of adherence may contribute to the pathogenesis of P. falciparum malaria, but has wider implications as an example of an infectious agent with the capacity to bind specifically to cell-associated or immobilized CS.